Press Releases

Alfa Chemistry: Photochromic Materials Exhibit Intriguing Optical Properties

Earlier this month, Alfa Chemistry Materials announces the offering of photochromic materials, a material characterized by its optical properties being able to change reversibly upon irradiation. In fact, this company, reputed for the supply of all kinds of materials, has previously launched a wide array of other functional materials such as charge transfer complexes, macrocycles, phthalonitriles & naphthalonitriles, pressure & heat sensitive recording materials, semiconducting materials, silane coupling agents, and UV absorbents.

Lung cancer test could identify high-risk patients before symptoms

A new diagnostic test for lung cancer could identify high-risk patients even before the onset of symptoms. Cscreen+ will provide an annual lung cancer screening test for high-risk smokers aged 45 and older using lateral flow technology. It will allow rapid early diagnosis and intervention, potentially saving thousands of lives and significantly reducing costs of diagnosis and care associated with late-stage disease. The test is being brought to market by iOmics Ltd., a diagnostics company based in Wales.

Accelerating Peptide Drug Research with Creative Peptides’ Premade Peptide Library

Creative Peptides constructed a versatile total peptide library with its proprietary peptide design platform to accelerate peptide drug research.

BOC Sciences Unveils Comprehensive Custom Synthesis Services

BOC Sciences unveils its comprehensive custom synthesis services for worldwide partners engaged in biopharmaceutical, chemical, and life science research.

Panthera Biopartners raises £10 million to accelerate its dedicated clinical trial site expansion across the UK and Western Europe

Panthera Biopartners has secured £10 million of investment from BGF and Gresham House Ventures, the latter investing on behalf of the Baronsmead VCTs. This investment round will be used to fund further expansion in the UK and Western Europe.

DNDi and BenevolentAI collaborate to accelerate life-saving drug discovery research in dengue

Globally Recognized Scientific Policy and Genomics Expert Genya Dana, Ph.D. Joins Avellino as Global Head of Health Policy

Avellino Lab USA, Inc. today announced Genya Dana, Ph.D., as Global Head of Health Policy for the company. Genya comes to Avellino from the World Economic Forum, where she served as its Head of Healthcare.

CD Formulation Launches Tailored Solutions for Increased Bioavailability Excipients

Alfa Chemistry Launches a Chemistry-Focused Technology Platform: Advanced and Flexible

New ultra-sensitive lyo-ready PCR reagents unlock lower detection limits in lyophilised multiplex diagnostic assays

PCR Biosystems has expanded its comprehensive range of diagnostic reagents with the launch of a lyophilisable 4x RT-qPCR reagent mix designed for ultra-sensitive high-throughput detection of RNA sequences.

BioIVT Appoints Jennifer Murphy as Senior Vice President of Global Commercial Operations

Jennifer has more than 16 years’ commercial leadership experience in the diagnostics and life sciences industries.

Hataali wins US patent for the use of blockchain in advanced medicinal therapy products

Medical Device Manufacturer, Canterbury Scientific Limited, Completes Investment into Aptatek BioSciences, Inc. Developing Advanced In-Home Monitoring of Chronic Disease

Canterbury Scientific Limited, a leading global developer and manufacturer of medical devices, announced it has completed its investment into Aptatek Biosciences, Inc., a developer of in-home health monitoring solutions for patients with chronic disease. The investment, coupled with an option to manufacture, has been confirmed upon completion of a US$4 million seed funding round led by hard science investment firm IP Group, Inc. and includes the National PKU Alliance (NPKUA)

MicrobioSeq Releases Microbial Transcriptomics for Disease Research and Drug Development

MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a good reputation for providing reliable de novo sequencing, genotyping, microarray, and bioinformatics services. With years of experience in the pharmaceutical and life science sectors, CD Genomics has announced Microbial Transcriptomics solutions, which hold promise in uncovering novel ways to treat disease and improve human health.

Ultralow Input RNA-Seq Service Now Available by CD Genomics RNA Solutions Platform

RNA Solutions is a platform that offers services for the revolutionizing study of RNA, targeting both coding and non-coding RNAs of different physiological functions. The scientists at CD Genomics are ready to help detect various types of RNA via meticulous and integrative approaches. CD Genomics is proud to launch the ultralow input RNA-seq service using leading-edge Illumina sequencing techniques.

Creative Peptides Rolls Out PNA FISH Probes with High Sensitivity and Specific Hybridization

Creative Peptides rolls out a variety of PNA FISH probe products with high sensitivity and specific hybridization for worldwide customers.

BOC Sciences Updates Product List to Expand Access to Stable Isotope-Labeled Amino Acids

BOC Sciences today updated its product list to expand access to essential and non-essential stable isotope-labeled amino acids products for global customers.

Cytel Appoints First CMO, Propelling Expansion of Analytics and Innovation Available to Clinicians in Drug Development

Cytel Inc. has appointed Albert Kim, MD, PhD, as its first Chief Medical Officer (CMO)

Amerigo Scientific Announces the New Offering of 2-Aminonicotinamide

Amerigo Scientific introduces 2-Aminonicotinamide for scientific uses.

Creative Diagnostics Launches Staphylococcal Enterotoxin Antigens

Creative Diagnostics recently launches a range of natural and recombinant staphylococcal enterotoxin antigens.